TAB Bank Secures Nearly $70 Million in 2025 Q3 Financing Deals, Empowering 200 Businesses Nationwide

OGDEN, Utah, Oct. 23, 2025 (GLOBE NEWSWIRE) — TAB Bank successfully closed $67.3 million in credit facilities across 200 deals during the third quarter of 2025. The financing includes a diverse range of loans such as working capital, equipment, small business lines of credit, small business term loans and accounts receivable funding across numerous sectors. […]

Pumpkin Pet Insurance Now Part of the PetDesk Pet Insurance Guide for Smarter, Connected Pet Care

Pumpkin Pet Insurance, one of the nation's fastest-growing pet insurance and wellness brands, is now part of the PetDesk Pet Insurance Guide- a trusted resource within the PetDesk app – the highest-rated pet health app on the iOS app store with over 7 million users. This new partnershipfurthers Pumpkin's commitment to making pet insurance education

/C O R R E C T I O N — Melinda’s Foods LLC/

In the news release, Melinda's Hot Sauce Ignites the Nation's Top Pitmasters at the 2025 Open Fire Meat Up, issued 23-Oct-2025 by Melinda's Foods LLC over PR Newswire, we are advised by the company that “Wednesday” has been changed to “Thursday” in the 2nd paragraph. The complete, corrected release follows: Melinda's Hot Sauce Ignites the

Bronstein, Gewirtz & Grossman, LLC Encourages Western Alliance Bancorporation (WAL) Stockholders to Inquire about Securities Investigation

NEW YORK, NY, NY / ACCESS Newswire / October 23, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Western Alliance Bancorporation ("Western Alliance" or "the Company") (NYSE:WAL). Investors who purchased Western Alliance securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s

Pomerantz LLP Moves Forward with Class Action Lawsuit Against KBR, Inc. – KBR

NEW YORK CITY, NY / ACCESS Newswire / October 23, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against KBR, Inc. ("KBR" or the "Company") (NYSE:KBR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

Leading Global Cancer Center to Integrate Triomics AI Platform to Improve Clinical Trial Screening

Triomics, an oncology-focused generative AI company, today announced a collaboration through Memorial Sloan Kettering (MSK) Cancer Center's iHub and Clinical Research Innovation Consortium (CRIC) programs to deploy Triomics' AI-powered clinical-trial matching and screening system in MSK active clinical trials. Triomics previously worked with MSK as a participant in the 2024 Cohort of MSK's selective iHub

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Zynex, Inc. (ZYXI) And Encourages Stockholders to Reach Out

NEW YORK CITY, NY / ACCESS Newswire / October 23, 2025 / Attorney Advertising Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Zynex, Inc. ("Zynex" or "the Company") (NASDAQ:ZYXI). Investors who purchased Zynex securities prior to March 13, 2023, and continue to hold to the present, are encouraged to

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Globe Life Inc. (GL) and Encourages Stockholders to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / October 23, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL). Investors who purchased Globe Life securities prior to May 8, 2019, and continue to hold to the present, are encouraged

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Stockholders to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / October 23, 2025 / Attorney Advertising Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lifecore Biomedical, Inc. ("Lifecore" or "the Company") (NASDAQ:LFCR). Investors who purchased Lifecore securities prior to October 7, 2020, and continue to hold to the present, are encouraged

Scroll to Top